-+ 0.00%
-+ 0.00%
-+ 0.00%

FDA Clears Akeso Inc. to Begin Global Phase III Trial of Cadonilimab in First-Line Gastric Cancer

Reuters·12/12/2025 02:32:30

Please log in to view news